Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-NIDDM: Acarbose for Diabetes Prevention in IGT
NCT00629213Phase 3Completed
- Sponsor
- GWT-TUD
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by GWT-TUD. Status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00629213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629213.